Observational studyBMC surgery2026
A prospective observational cohort study comparing perioperative outcomes, complications, and quality of life between surgical procedures for female stress urinary incontinence.
Observational study in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveTo compare perioperative outcomes, complications, and quality of life between tension-free vaginal tape obturator (TVT-O) and retropubic tension-free vaginal tape exact (TVT-E) procedures for female severe stress urinary incontinence (SUI).
methodsThis prospective cohort study enrolled women undergoing surgery for severe stress urinary incontinence (December 2023-February 2025). Patients were grouped by procedure (TVT-O vs. TVT-E). We compared perioperative data, complications, quality-of-life scores (ICI-Q-SF, IIQ-7, PISQ-12 at 6 and 12 months), and 12-month objective cure rates. Kaplan-Meier curves assessed cumulative recurrence.
resultsOf 120 patients enrolled (TVT-O: 66; TVT-E: 54), baseline characteristics were comparable (P > 0.05). Operative time was significantly shorter in the TVT-O group (P < 0.001), with no significant differences in blood loss, catheterization time, or hospital stay. Complication rates were similar (TVT-O: 21.21% vs. TVT-E: 18.52%, P = 0.710), including specific complications like groin pain. Both groups showed significant postoperative quality-of-life improvements (P < 0.001), but between-group differences were not significant. At 12 months, objective cure rates and cumulative recurrence-free survival were comparable between groups.
conclusionBoth TVT-O and TVT-E are safe and effective for severe SUI, significantly improving quality of life. TVT-O offers shorter operative time with equivalent efficacy and complication rates to TVT-E.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.